BCL2L11 and breast carcinoma: For example, in pancreatic and breast cancer cells, MYC expression products bind to and activate the promoters of the pro-apoptotic proteins BIM and BID, thereby facilitating the initiation of mitochondrial responses to apoptotic stimuli [62–64].